Vikas Multicorp Limited (BSE:542655) agreed to acquire an unknown stake in Advik Laboratories Limited (BSE:531686) from Advik's promoters on January 12, 2021. The deal is subject to the completion of due diligence, the achievement of time settlement with the Bank and revocation of suspension of trading in equity shares of Advik. The Board of Directors of Vikas in principally approved the acquisition of Advik and to enter into a non-binding memorandum of understanding for acquisition of promoters' stake.